Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioCatalytics

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of custom and off-the-shelf enzymes designed to develop and implement an enzyme-based process. The company's custom and off-the-shelf enzymes include non-natural amino acids, beta-amino acids, chiral amines, ketoreductases and other compounds, enabling pharmaceutical and fine chemical companies to discover and develop better routes for the production of key chemical products.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Discovery Tools (Healthcare)
Acquirer
Primary Office
  • 129 North Hill Avenue
  • Suite 103
  • Pasadena, CA 91106
  • United States

BioCatalytics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BioCatalytics‘s full profile, request access.

Request full access to PitchBook

BioCatalytics Executive Team (1)

Name Title Board
Seat
Contact
Info
David Rozzell Ph.D President